Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
42,194,093
-
Total 13F shares
-
13,053,454
-
Share change
-
-222,728
-
Total reported value
-
$378,290,053
-
Price per share
-
$28.98
-
Number of holders
-
43
-
Value change
-
-$6,901,273
-
Number of buys
-
25
-
Number of sells
-
16
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) as of Q2 2021
As of 30 Jun 2021 Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,053,454 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, RTW INVESTMENTS, LP, Cormorant Asset Management, LP, FRAZIER MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, Jefferies Group LLC, BlackRock Inc., and VANGUARD GROUP INC.
This table shows 43 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.